Trademark: 90836060
Word
EVAMPLIX (BALSTILIMAB)
Status
Dead
Status Code
606
Status Date
Monday, May 1, 2023
Serial Number
90836060
Mark Type
3000
Filing Date
Monday, July 19, 2021
Published for Opposition
Tuesday, August 2, 2022
Abandoned Date
Monday, May 1, 2023

Trademark Owner History
Agenus Inc. - Owner At Publication

Classifications
5 pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases
The mark consists of a two dimensional representation of three interconnected cubes, with a single cube resting on top of two cubes to the right of the term "EVAMPLIX," which is above the term "(BALSTILIMAB)".
"BALSTILIMAB"

Trademark Events
May 1, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 1, 2023
Abandonment - No Use Statement Filed
Sep 27, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2022
Published For Opposition
Jul 13, 2022
Notification Of Notice Of Publication E-Mailed
Jun 30, 2022
Approved For Pub - Principal Register
Jun 29, 2022
Teas/Email Correspondence Entered
Jun 29, 2022
Correspondence Received In Law Office
Jun 29, 2022
Teas Response To Office Action Received
Dec 30, 2021
Notification Of Non-Final Action E-Mailed
Dec 30, 2021
Non-Final Action E-Mailed
Dec 30, 2021
Non-Final Action Written
Dec 30, 2021
Previous Allowance Count Withdrawn
Nov 23, 2021
Withdrawn From Pub - Og Review Query
Nov 9, 2021
Approved For Pub - Principal Register
Nov 9, 2021
Examiner's Amendment Entered
Nov 9, 2021
Notification Of Examiners Amendment E-Mailed
Nov 9, 2021
Examiners Amendment E-Mailed
Nov 9, 2021
Examiners Amendment -Written
Nov 8, 2021
Assigned To Examiner
Sep 22, 2021
Notice Of Design Search Code E-Mailed
Sep 21, 2021
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24